Professor Raj Mookerjee

Professor Raj Mookerjee is a consultant hepatologist based in London, with a specialist interest in management of cirrhosis complications and alcoholic liver disease. His practice also addresses management of fatty liver and derangement of liver function tests, in addition to endoscopic management of liver conditions including varices. He privately practices at The Royal Free Private Patient Unit and London Medical, Marylebone.  His NHS practice base is at The Royal Free London NHS Foundation Trust.

Professor Mookerjee's work specifically centres around the complications of chronic liver disease and liver failure. He's at the forefront of research for new therapies for portal hypertension and managing cirrhosis complications, including the application of innovative remote monitoring of cirrhosis to provide early intervention, and incorporating novel biomarkers to assess liver disease progression. Recently, Professor Mookerjee and his team were the first to trial the CirrhoCare app, which will allow hepatologists to remotely monitor liver disease patients. 

Professor Mookerjee qualified with a First Class BSc and then a Distinction MBBS from University College London (UCL). After graduating, he went onto pursue a specialist training program in gastroenterology and hepatology within the Central and North London Deanery, including Liver transplantation experience at The Royal Free. Professor Mookerjee completed his specialist training in 2005. During this period, he also completed a PhD that focussed on new mechanisms for portal hypertension. He then took up a post as Consultant Hepatologist at UCLH and went onto to lead that service before its migration and integration into the Royal Free Liver and Transplantation Unit in 2010, where he continues to be based. 

He also has an esteemed academic research and teaching career which currently sees him as Professor of Translational Hepatology for leading institution University College London, and he is also a Skou Professor of Hepatology at Aarhus University in Denmark. Additionally, his international role also includes him serving on the steering committee for the European Foundation for Chronic Liver Failure research (EF-CLIF), and on the educational committee for the European Association for the Study of the Liver (EASL). 

He is also within a professional working group that has written the International Guidelines for managing cirrhosis complications. Nationally, he serves on the Committee for Hepatology Training and also within the Board of the British Association of Studies of the Liver (BASL), as Secretary-elect, and within a special interest group for managing portal hypertension. He is also a fellow of the Royal College of Physicians.  

Professor Mookerjee's research over the last two decades spans the breath of translation including delivery of First-in-Man studies in cirrhosis patients. He has been principal investigator of many multi-centre clinical trials and has published in many peer-reviewed journals, with an h-index of 50. He is a regular invited speaker to many international meetings and is passionate about seeing new concepts reach early clinical translation for the benefit of patients.